Glossary
Paul L Bellamy
FDA Investigator Details
Paul L Bellamy
Visit Investigator ProfileInvestigation Details
Last Issued Date
August 22, 2016
Conversion Rate
0
% Conversion
No. of 483’s Issued
2
Warning Letters Issued
0
Countries Inspected
USA
FDA Investigators having one site common
Detailed Analysis
Approach:
Mr. Bellamy tends to be meticulous and detail-oriented, focussing on data driven quality assurance standards. He prefers to make objective assessments based on documented evidence and is particularly stringent on label directions and their substantiation via appropriate testing protocols.
Profile:
Paul L Bellamy is an FDA investigator heavily focused on stability testing programs and the accuracy of beyond use dates. He shows astute attention to detail and is especially concerned with discrepancies in labelling and documentation in relation to the potency of drug products over the duration of their shelf life.
Top Process Types:
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now